Three-finger fold toxins are miniproteins frequently found in Elapidae snake venoms. This fold is characterized by three distinct loops rich in b-strands and emerging from a dense, globular core reticulated by four highly conserved disulfide bridges. The number and diversity of receptors, channels, and enzymes identified as targets of three-finger fold toxins is increasing continuously. Such manifold diversity highlights the specific adaptability of this fold for generating pleiotropic functions. Although this toxin superfamily disturbs many biological functions by interacting with a large diversity of molecular targets, the most significant target is the cholinergic system. By blocking the activity of the nicotinic and muscarinic acetylcholine receptors or by inhibiting the enzyme acetylcholinesterase, three-finger fold toxins interfere most drastically with neuromuscular junction functioning. Several of these toxins have become powerful pharmacological tools for studying the function and structure of their molecular targets. Most importantly, since dysfunction of these receptors/enzyme is involved in many diseases, exploiting the three-finger scaffold to create novel, highly specific therapeutic agents may represent a major future endeavor.
The three-finger fold proteins Three-finger fold proteins (3FPs) form a structural superfamily largely distributed in Metazoans, including marine organisms (sea urchin, tunicate), nematode (C. elegans), fruit fly (D. melanogaster), and several vertebrates (Galat 2008) . They are characterized by a short peptidic chain (ca. 60-80 residues) and a high content of disulfide bridges (often four or five and in rare cases three or six). In the Structural Classification of Proteins (http://scop.mrc-lmb.cam.ac.uk/sc op/data/scop.b.h.h.A.html) database, the 3FPs belong to the snake toxin-like superfamily of proteins, which includes sequences of soluble snake venom toxins and of extracellular domains of cell surface receptors [CD59, bone morphogenetic protein receptor Ia and transforming growth factor b receptor ectodomains, urokinase plasminogen activator surface receptor: urokinase plasminogen activator receptor (uPAR)-lymphocyte antigen 6 (Ly6)]. In the PFAM database (http://pfam.xfam.org/clan/uPAR_Ly6_toxin) this superfamily is called uPAR/Ly6/CD59/snake toxin-receptor superfamily, and it includes 2583 sequences distributed within seven subfamilies. As revealed by its name, members in this superfamily are structurally characterized by their three distinct b-stranded loops that emerge from a dense, globular core containing four conserved disulfide bridges (Fig. 1) . The spacing and conserved connectivity of the eight cysteine residues (C1-C3, C2-C4, C5-C6, C7-C8), which secure the stability of the hydrophobic core and the structural integrity of the 3FP, dictate the structural signature of this superfamily (Fig. 1a) . Only the first of the three 3FP domains of the urokinase plasminogen activator receptor (uPAR) conserves a 3FP scaffold despite absence of a fourth disulfide bridge (Llinas et al. 2005) . Therefore, this signature appears to be sufficient for dictating the general structure of the 3FPs. In contrast, the variability in sequence and in the length of the loops and turns correlates with the functional diversity associated with this fold. Genes encoding 3FPs are found in the genomes of numerous terrestrial and marine organisms such as tunicate, sea urchin, salamander, nematodes, insects, and vertebrates (Galat 2015) . These genes are similarly organized, with three exons split by two introns. The first exon encodes the signal sequence, the second exon encodes the N-terminal part of the protein up to the middle of loop II, and the third exon encodes the rest of the molecule. When the 3FP is associated with a GPI-anchor domain, as is the case for most members of the Ly6-uPAR family, this domain is encoded by an additional sequence in the third exon. The nucleotide sequences of exon 1 are highly conserved within the family, whereas those of the other two exons are highly variable. The Homo sapiens genome encodes about 45 proteins containing one (Ly6, extracellular domains of transforming growth factor-b, bone morphogenetic proteins, and CD59) to three 3FP domains (uPAR) (Galat 2008) . The Ly6/uPAR family members are subdivided into membranetethered (through a GPI-anchor domain) or secreted 3FPs. Expression of Ly6/uPAR proteins is widespread although variable across cell types and tissues, is tightly regulated in a spatiotemporal manner, and is often correlated with cellular differentiation. Thus, members of this protein family are involved in various physiological processes such as inflammation, cytokine production, immune cell maturation, regulation of signaling cascades, cell-cell interaction, or tissue regeneration, a feature highlighting the exceptional capacity of this scaffold to trigger protein-protein recognition and association (Galat 2015; Loughner et al. 2016) . Snake venom toxins that belong to the 3FP superfamily share this ability to recognize a wide diversity of molecular targets (see below).
Some of the functional processes controlled by Ly6/uPAR proteins concern the regulation of the cholinergic functions (Tsetlin 2015; Loughner et al. 2016) . For example, Lynx1 is a membrane-tethered 3FP that co-localizes with nicotinic acetylcholine receptors (nAChRs) and modulates their function in the brain (Miwa et al. 1999; Ibanez-Tallon et al. 2002) . Lynx1 forms stable complexes with the a4b2 nicotinic acetylcholine receptor (nAChR) subtype, lowering the affinity for the agonist, hastening desensitization and retarding its recovery from desensitization (Ibanez-Tallon et al. 2002) . This 3FP is thus considered as a cholinergic brake, which limits the visual cortex plasticity in the adult animal (Morishita et al. 2010) or decreases learning mechanisms in the brain (Miwa and Walz 2012) . Lynx1 also acts Fig. 1 The 3FP scaffold. (a) Typical cysteine framework of the 3FPs including the four highly conserved disulfide bridges (black) and the possible fifth additional bonds (red and green). (b) Tridimensional structures of monomeric short, long, and non-conventional 3FTs, of non-covalent or covalent 3FT dimers, and of a membraneanchored 3FP (showed here with a schematic anchor).
on nAChRs as a pharmacological chaperone, first by affecting the assembly of nascent a4 and b2 subunits and altering the stoichiometry of the receptor population that reaches the plasma membrane, and then by shifting the nAChR stoichiometry to the low sensitivity (a4) 3 (b2) 2 pentamers, primarily through this interaction in the endoplasmic reticulum, two events consistent with the observed effects on nicotinic-elicited currents (Nichols et al. 2014) . Another GPI-anchored 3FP, the prostate stem cell antigen, antagonizes the a7 nAChR subtype and prevents the programmed cell death in parasympathetic neurons (Hruska et al. 2009 ). Secreted Ly-6/uPAR-related proteins (SLURP-1 and SLURP-2) are largely present in (the) non-neuronal nicotinic system(s) and are expressed by a variety of epithelial (Horiguchi et al. 2009 ) and immune cells (Moriwaki et al. 2007) . These proteins are considered to be autocrine/paracrine regulators that control the growth, differentiation and malignant transformation of epithelial cells (Arredondo et al. 2007a,b) . For instance, in keratinocytes, SLURP-1 and SLURP-2 interact with a7-and a3-containing nAChRs, respectively, to inhibit or promote cell proliferation, and hence, regulate malignant transformation (Arredondo et al. 2005 (Arredondo et al. , 2006 (Arredondo et al. , 2007a Lyukmanova et al. 2016a) . Finally, in the prostate, testis, and in neurons, a secreted 3FP named prostate and testis expression protein participates in the control of fertility and reproduction and in the modulation of neuronal transmission by interacting with nAChRs (Levitin et al. 2008 ).
The three-finger fold toxins
Venom toxins have been selected during evolution to confer on venomous animals the capacity to subdue their prey and protect themselves against predators. Despite the huge diversity of animal toxins, most belong to a limited number of enzymatic (serine proteases, phospholipases, metalloproteinases, etc) and non-enzymatic (three-finger fold toxins, Kunitz peptides, knottin peptides, etc) protein superfamilies. These have been recruited convergently in various organisms to perform similar functions (Fry 2005; Sunagar et al. 2013) . While the enzymatic toxins contribute mainly to the slow immobilization and digestion of the prey, the non-enzymatic toxins spur quick immobilization via their neurotoxic or cardiotoxic effects. Snake toxins have arisen from recruitment of genes encoding ancestral non-toxic proteins and selective expression in venom glands (Fry 2005) . Thus, three-finger fold toxins (3FTs) most likely evolved from 3FPs via gene duplication and accelerated evolution leading to the potentiation of their neurotoxic property. Optimization of the toxic properties can be correlated either with the suppression of the GPI-anchor or with the deletion of the additional disulfide bridge in loop I present in 3FP and in unconventional elapid neurotoxins with weak potency (weak neurotoxin: WTX) (disulfide bridge in red in Fig. 1a ). This toxin family was initially thought to be specific to Elapidae snakes (cobras, mambas, najas, kraits, coral snakes, etc), yet 3FTs from the Colubridae (Fry et al. 2003; Pawlak et al. 2006 Pawlak et al. , 2009 and Viperidae families (Doley et al. 2008; Fry et al. 2008) were later discovered, revealing the broad taxonomic distribution of this family. Nevertheless, in Elapidae venoms the ratio of 3FTs relative to the other toxins can be predominant, as demonstrated by recent proteomic and transcriptomic analyses of various venoms. For instance, in the venom gland of the king cobra Ophiophagus hannah or the mamba Dendroaspis angusticeps, 3FTs represent 70% of all the toxins (Vonk et al. 2013; Lauridsen et al. 2016) , whereas in the coral snake Micrurus tschudii this preponderance reaches 95% (Sanz et al. 2016) . Recently, while studying the molecular evolution of 3FTs, Fry and colleagues reported that three-finger fold (3FF) neurotoxins are involved in a coevolutionary arms race with receptors of prey species, and evolve under the influence of positive selection, whereas 3FF cytotoxins interacting nonspecifically with cell membranes are constrained by negative selection (Sunagar et al. 2013) .
Sequences within the 3FT subfamily are more homogeneous than those within the 3FP superfamily, and their length is more constrained (60-74 amino acid residues). Several residues are highly conserved and seem to be involved in the stability or folding of the toxins (Gly before the fourth Cys, Pro after the fifth Cys, Asn after the eighth Cys) (Fig. 2a) . Although non-covalent (j-bungarotoxin) or covalent (irditoxin) dimeric forms of 3FTs have been described (Dewan et al. 1994 ) (Pawlak et al. 2009) (Fig. 1b) , most 3FTs are found as monomers. This is the case for the short (e.g., MT7, erabutoxin-a, fasciculins), long (e.g., a-cobratoxin, a-bungarotoxin), and non-conventional neurotoxins (e.g., bucandin, candoxin), which differ by the length of their N-or C-terminal extension and the presence of an additional disulfide bond in loop I (non-conventional toxins) or loop II (long neurotoxins) (Fig. 2a) . Currently, thirty tridimensional structures of distinct 3FTs are available in the Protein Data Bank, allowing us to examine how local structural deviations may cause departure from the canonical 3FT scaffold. The main differences concern the length of the b-sheets that rigidify the three loops and the flexibility/orientation of these loops, which may dictate the concavity of the molecule. In addition, the presence of an additional disulfide bond at the tip of either loop I or loop II may induce a twist or the presence of a short helical segment in these regions, as shown for bucandin and a-cobratoxin, respectively (Fig. 1b) . In fact, the recently solved crystallographic structure of mambalgin-1 revealed an extended loop II along with shorter loops I and III, with the latter forming either a short b-strand or a short single turn a-helix (Mourier et al. 2016) .
All these local structural variations support the multifunctional properties associated with the 3FP scaffold. Indeed, apart from the modulation of the cholinergic function, which will be developed in the next chapter, 3FTs may affect several physiological functions by interacting with a large diversity of molecular targets. Peculiarly and with no apparent physiological reasons, several 3FTs with atypical biological functions were isolated from the venom of black or green mambas. This is the case of mambalgins, which are pain-relieving peptides characterized by their capacity to inhibit acid-sensing ion channels (Diochot et al. 2012) . The same venom contain the toxins q-Da1a and q-Da1b, which interact selectively with a1 A -and a2-adrenoceptors Rouget et al. 2010) , and toxin Tx7335, characterized by a modified cysteine framework that acts to increase the potassium flow-through by reducing KcsA channel inactivation allosterically (Rivera-Torres et al. 2016) . The blocking action of calciseptine for the L-type Ca-channel (De Weille et al. 1991) and the platelet aggregation inhibition triggered by the antagonistic property of dendroaspin for the a IIb b3 integrin receptor had been described earlier (McDowell et al. 1992; Sutcliffe et al. 1994) . From various cobra venoms, hundreds of cardiotoxins/cytotoxins were identified and characterized by their ability to increase the heart rate and form pores in cell membranes by interacting with the phospholipids and, most particularly, the phosphatidylserine group of lipids (Bilwes et al. 1994; Konshina et al. 2011) . This group of toxins is the second largest group of 3FTs and it is associated with a major cardiotoxic effect. The cytolytic determinants in the cardiotoxins are spread over the three loops and they include both a hydrophobic patch extending from the middle to the bottom end of all loops and a row of positively charged lysine residues located at the top end (Kini and Evans 1989) . Differently, however, b-cardiotoxin isolated from the venom of the king cobra induces a significant decrease in the heart rate via a b-blocker activity (Rajagopalan et al. 2007) . Recently, toxins MmTX1 and MmTX2 from coral snake (Micrurus mipartitus) venom were found to allosterically modulate the GABA A receptor activity, leading to a potentiation of the receptor opening and desensitization by the agonist (Rosso et al. 2015) . In conclusion, the number of receptors, channels, and enzymes targeted by 3FTs is increasing continuously, expanding our knowledge and highlighting the unique capacity of this fold to trigger pleiotropic functions.
3FTs affecting the cholinergic system
The cholinergic system Although 3FTs perturb various biological functions, the cholinergic system remains the most targeted at the molecular level. The past 50 years have accumulated findings, first by Chang and Lee, who showed that a-bungarotoxin from B. multicinctus venom blocks the muscle-type (a 1 ) 2 bcd nAChR (Chang and Lee 1963) and then by prompting the use of this toxin as a pharmacological tool to study the function and structure of this receptor (Changeux et al. 1970) . Then, 3FTs from Dendroaspis venoms were shown to inhibit acetylcholinesterase (AChE) (Rodriguez-Ithurralde et al. 1983) and modulate muscarinic acetylcholine receptors (mAChRs) (Adem et al. 1988) and their respective modes of action were described in detail over the subsequent years.
3FTs affect several actors of the cholinergic neurotransmission system, which includes the acetylcholine (ACh) synthesis (choline acetyltransferase) and degradation (cholinesterases) enzymes controlling the ACh concentration, the nAChRs, mAChRs, and transporter proteins. In the central nervous system, ACh is involved in thermoregulation, motor control and cognitive processes such as attention, memory, learning, and alertness. In the peripheral nervous system, via parasympathetic innervation, ACh controls functions such as smooth muscle contraction, homeostasis, modulation of cardiac rate and force, and glandular secretion (Westfall and Westfall 2011) . Outside the nervous system, biological roles of ACh were largely described during the past decade. The non-neuronal cholinergic system can modify and control cell proliferation, differentiation, secretion, migration, apoptosis, and locomotion, along with angiogenic events, immune functions, cytoskeletal organization, and movements of ions and water (Wessler and Kirkpatrick 2008; Campoy et al. 2016) . In turn, dysfunction of the cholinergic system is associated with several central and peripheral pathologies such as Alzheimer's and Parkinson's diseases, schizophrenia, drug addiction and neuromuscular disease, pain, asthma, disorders of intestinal motility, and cardiac and urinary bladder dysfunctions, respectively.
The synthesis of ACh requires choline and acetyl coenzyme A (acetyl-CoA) and their coupling is catalyzed by choline acetyltransferase. In synaptic vesicles, ACh is accumulated by a vesicular acetylcholine transporter and is driven by the transvesicular proton gradient linked to an ATPase enzyme (Parsons 2000; Brunton et al. 2011; Deiana et al. 2011) . Following the depolarization of the pre-synaptic neuron and a subsequent Ca 2+ influx, neurotransmitter vesicles fuse to the pre-synaptic membrane and release ACh into the synaptic cleft, permitting its transient interaction with pre-and post-synaptic nAChRs and mAChRs. Then, within milliseconds, ACh hydrolysis by AChE or butyrylcholinesterase (BChE) (see below) generates acetic acid and choline ready for reuptake and re-synthesis (Deiana et al. 2011 ; Van der Zee and Keijser 2011).
The mAChRs are widely distributed throughout the human body where they mediate distinct physiological functions depending on their location and receptor subtype (Caulfield and Birdsall 1998) . This superfamily of metabotropic receptors includes five distinct subtypes (M1 to M5) that all belong to the seven-transmembrane G-protein-coupled family of receptors (Caulfield 1993; Eglen 2005; Ishii and Kurachi 2006) . The nAChRs for their part are Cys-loop members of the ligand-gated ion channels superfamily of receptors and include one muscle-type and several neuronal subtypes Karlin 2002 ). All subtypes are homo or heteropentameric assemblies consisting of variable combinations of a (a1-a10), b (b1-b4), c, and d/e (embryonic/adult muscle) subunits whose circular arrangement forms the central transmembrane channel. nAChR activation causes a rapid increase in the cell permeability to Na + and Ca 2+ ions accompanied by cell membrane depolarization and excitation (Guo and Lester 2007; Deiana et al. 2011) . Finally, the cousin enzymes AChE and BChE form a group of serine a/b hydrolases (http://bioweb.ensam.inra.fr/ ESTHER/general?what=index) that both hydrolyze the natural substrate ACh (only BChE also hydrolyzes the non-natural substrate butyrylcholine) Sussman 2005, 2008) . AChE is found primarily in neuromuscular junctions and neuronal synapses and on red blood cell membranes, whereas BChE is found primarily in blood plasma. Hence, this is AChE that plays the key role in ending cholinergic neurotransmission. AChE inhibitors are either natural or synthetic substances that interfere with the breakdown of ACh and prolong its action onto the nAChRs and mAChRs. To date the only natural peptidic inhibitors of AChE known are the 3FTs, fasciculins.
3FT pharmacophores
To decipher the molecular determinants that permit the interaction of 3FTs with cholinergic receptors and enzymes, the structure-activity relationships of representative members and their targets have been studied. In the case of the nAChRs, five toxin/receptor couples have been studied using site-directed mutagenesis of three recombinantly expressed toxins along with binding and functional assays on the muscle-type or neuronal a7 nAChRs. Binding of the shortchain erabutoxin-a (Tr emeau et al. 1995) and the long-chain a-cobratoxin (Antil et al. 1999 ) to muscle-type nAChR was found to involve highly conserved residues such as Lys-27, Trp-29, Asp-31, and Arg-33 at the tip of loop II and Lys-47 in loop III (erabutoxin numbering, Fig. 2 ). The critical role of an Arg side chain at the tip of loop II was confirmed in both abungarotoxin (Rosenthal et al. 1999 ) and the non-conventional WTX toxin (Lyukmanova et al. 2016b) (Fig. 2) . In contrast, some differences in the mode of interaction of these toxins with this receptor were also evidenced, such as the distinctive functional role of the tip of loop I versus the Cterminal tail in short versus long neurotoxins (Antil et al. 1999) . In fact, comparison of the pharmacophores used by acobratoxin to interact with either the muscle-type or the neuronal a7 nAChRs highlighted the shared contribution of a particular set of residues . Similarly, WTX residues Arg-31 and Arg-32 were found to contribute to interaction with either of these two receptor subtypes (Lyukmanova et al. 2016b) . However, some of the residues within this mandatory set in acobratoxin are more specific for muscle-type (Lys-23 and Lys-49) than for a7 nAChRs recognition (Ala-28, Lys-35, and Cys-26-Cys-30) (Antil-Delbeke et al. 2000) .
In the case of the AChE inhibitor, fasciculin 2 (Fas2), a mutagenesis approach conducted to validate the structural analysis of the complex (see below) confirmed the critical role of Fas2 residues Arg-27, Pro-30, Pro-31 in the central loop II and the complementary role of other residues in loop II (Arg-24, Lys-32, Met-33) and in loop I (Thr-8, Thr-9, Arg-11) in interaction with the peripheral site of the enzyme (Fig. 2) (Marchot et al. 1997) . In fact, common determinants were identified by the structural and the mutagenesis approaches, yet only those Fas2 residues residing central to the complex interface were found to provide the critical contacts leading to AChE inhibition, whereas the surrounding residues were contributing more to binding affinity.
Finally, functional analysis of several synthetic variants of the muscarinic toxin MT7 highlighted the crucial role of loop II residue Arg-34 in determining high affinity and selectivity for the muscarinic acetylcholine receptor (mAChR) subtype M1, whereas additional residues in loop I (Trp-10), loop II , and loop III (Arg-52) had only a complementary role for complex formation (Fig. 2) (Mourier et al. 2003; Marquer et al. 2011) . Similarly, the positively charged residues located at the tip of loop II of toxin WTX, which recognizes the various mAChRs subtypes with low micromolar affinity and limited specificity, were found to be crucial for these interactions (Lyukmanova et al. 2015) .
These studies identify the tip of the central loop II, and in particular the positively charged side chains that emerge from it, as the main determinants of 3FTs for selective recognition of their respective cholinergic targets.
Structural characterization of complexes of cholinergic toxins with their molecular targets
Complementarily to the structure-function relationship studies described above, the modes of binding of several 3FTs relative to their cholinergic targets were also studied at the molecular level. X-ray crystallography structures were solved and homology models proposed for six 3FT-target complexes or proposed, respectively. These structural studies revealed or assessed the nature of the pharmacophore used by the 3FTs to interact with nAChR and mAChR subtypes or with AChE, and provided a molecular basis for a detailed comparison of their modes of interaction.
Long a-neurotoxin/receptor complexes: Pentameric a-cobratoxin/AChBP complex. Acetylcholine binding proteins (AChBP), as soluble functional and structural surrogates of the extracellular ligand-binding domains of the nAChRs, along with some engineered AChBP-nAChR chimeras, have been used for crystallographic exploration of the modes of binding of a few peptidic and many organic cholinergic ligands to the nAChRs. Among them, the structure of the pentameric a-cobratoxin-AChBP complex provided a first tridimensional picture of the competitive antagonistic property of a-cobratoxin relative to ACh, because of their overlapping binding sites (Fig. 3) (Bourne et al. 2005) . Each toxin molecule is inserted between the principal and complementary faces of a subunit interface, where the tip of loop II occupies the agonist binding pocket underneath loop C, characterized by the disulfide bond between two adjacent cysteine residues at its tip. Positional reorganization of the two loops that border the binding pocket, i.e., loop C from the principal face and loop F from the complementary face of the interface, along with slight rearrangements in the toxin loops are associated with complex formation. a-Cobratoxin residues Phe-29 and Arg-33 at the tip of loop II make hydrophobic and aromatic interactions with the conserved , Lymnaea AChBP numbering) in the binding pocket. Different from earlier predictions, this is the side chain of Phe-29, and not that of Arg-33, that occupies the center of the aromatic binding pocket and contributes to hydrophobic interaction with the functionally crucial Trp-143 in AChBP. Apical apposition of the tip of a-cobratoxin loop I relative to loop C, along with interaction of Phe-69 in the toxin C-terminal tail, also with loop C, strengthen toxin anchorage central to the interface. In turn, residues on the loop II edge lay proximal to the complementary loop F, where they provide more minor contribution to complex cohesion.
Pentameric a-bungarotoxin/a7-AChBP chimera complex. A chimera assembled from the peripheral loops and binding pocket residues of the human a7 ligand-binding domain grafted onto an AChBP scaffold was crystallized as a pentameric a-bungarotoxin complex (Huang et al. 2013) . Despite the use of another long neurotoxin and an engineered receptor, and apart from the tip of the toxin loop II being ca. 2 A closer to the principal face of the binding interface, this structure was nearly superimposable with that of the a-cobratoxin-AChBP complex.
Long a-neurotoxin/a-subunit complexes Monomeric a-bungarotoxin/a1 or a9 subunit complexes. Monomeric complexes of a-bungarotoxin bound to the ligand-binding domain of the human muscle-type a1 and neuronal a9 subunit, respectively, yielded very consistent structural information to each other and relative to the earlier Three-finger modulators of cholinergic functionssolved pentameric complexes (Dellisanti et al. 2007; Zouridakis et al. 2014) . The only differences reside in the orientation of the bound toxin, slightly twisted toward the membrane side of the a1 or a9 ligand-binding domain, and in the position of the tip of loop II, which binds deeper (4.5 A) into the agonist binding pocket as restored in silico by associating two subunits. Such differences may be due to the absence of a complementary subunit, which in pentameric complexes provides interactions that stabilize the toxin.
All these complexes encompass an interfacial surface area between the bound 3FT and the subunit interface of ca. 1100 A 2 . In the 3FT, the tip of loop II along with an aromatic residue from the C-terminus provide the major anchors to this interface, whereas loop I contributes fewer and weaker interactions only and loop III does not interact at all. These structural interpretations are fairly consistent with those raised from the mutagenesis data, including the nature of the pharmacophores involved into complex cohesion (Fig. 2) . Availability of a structure of either a long or a short a-neurotoxin bound to a pentameric, fulllength nAChR would certainly provide relevant complementary information.
The fasciculin/AChE complex Analysis of crystal structures of complexes of Fas2 with various AChEs show loop II positioned at the center of the peripheral site interface, along with peripheral buttressing contributions by loop I and by the C-terminal (Bourne et al. 1995; Harel et al. 1995; Kryger et al. 2000) (Fig. 3) . In loop II, the fasciculin-specific Pro-30/Leu-35 segment, centered around the critical Met-33, along with Arg-27 and Arg-37 at the loop II edge, are instrumental for anchoring the toxin at the entrance of the active site gorge. At the tip of loop I, the Thr-7/Ala-12 segment, also characteristic of fasciculins, along with Tyr-4 and Tyr-61 in the N-and C-terminal ends of the toxin, provide stabilizing interactions with the AChE surface. Here again, loop III does not contribute to the complex interface. Compared with structures of unbound Fas2 and AChE, the main rearrangements observed are associated with constraints in the inherent flexibility of the Fas2 loops and several AChE surface loops. Compared with the above described neurotoxin-receptor complexes, it is noteworthy that all these complexes are stabilized by aromatic and/or cation-aromatic interactions between the bound toxin and its receptor, consistent with their low dissociation constants (Kd values pM to nM).
The MT7/M1 mAChR complex Although no experimental structure of a complex between an allosteric toxin and a mAChR is available, a tridimensional model of the allosteric toxin MT7 bound to the M1 mAChR subtype was obtained based on double mutant cycle analysis data (Marquer et al. 2011) (Fig. 3) . These data suggested that MT7 binding requires a receptor dimer and primarily involves loop II of the toxin and the extracellular loop e2 of the receptor. The best model obtained showed MT7 loops II and III interacting with loop e2 in one M1 receptor in the dimer and loop I of the same MT7 molecule interacting with loop e2 in the second receptor. As a result, Arg-34 lays proximal to M1 residues Trp-400 and perhaps Glu-397, whereas loop III residue Arg-52 is properly positioned for interaction with M1 residue Glu-170. In addition, loop I residue Trp-10 could interact with Trp-400 and perhaps Tyr-179 in the second receptor monomer. Here, all three loops of toxin MT7 appear to contribute to its interaction with the M1 mAChR, although loops II provide the main anchoring points as previously described for AChBP and AChE complexes.
In all these complexes, positively charged residues at the tip of the toxin loop II play a central role in the interaction, whereas on the target side, residues forming an aromatic pocket or surface are always implicated. Consequently, pication interactions are frequently observed, and these may also occur in the MT7-M1 complex.
Engineering of cholinergic toxins
Currently, more than 500 peptidic sequences of 3FTs are known, a testimony to the impressive variability in the 3FT loops within the three-finger scaffold and a boon for 3FT engineering. Mourier and coll. modified toxin a, a short a-neurotoxin specific for the muscle-type nAChR by replacing the tip of loop II by the equivalent cyclized tip of a-bungarotoxin that contains a fifth disulfide bond typical of long a-neurotoxins (a-bungarotoxin or a-cobratoxin). This produced a chimeric toxin able to bind to both muscle-type and neuronal a7 nAChRs (Fig. 4a) (Mourier et al. 2000) . This grafting enhanced the affinity of toxin a for the a7 nAChR by 20-fold, thereby asserting the role of a cyclized loop tip in nAChR subtype selectivity.
In turn, Ricciardi and coll. transformed the same toxin a into a valuable AChE inhibitor by replacing loop I, the tip of loop II, and the C-terminal residue by their counterparts in Fas2, thereby creating a chimeric toxin that displayed only 15-fold lower inhibitory potency than natural Fas2 (Fig. 4b) , whereas devoid of nAChR binding capacity (Le Ricciardi et al. 2000) . Subsequent crystallographic analysis of the chimera assessed for the transfer of the Fas2-specific concavity, opposite to that of toxin a, upon transfer of the Fas2 determinants into toxin a .
More recently, Fruchart-Gaillard and coll. engineered new 3FTs with original pharmacological profiles for the mAChRs or adrenoceptors (Fruchart-Gaillard et al. 2012) . While toxin MT7 is a specific allosteric modulator of the M1 mAChR, toxin MT1 recognizes both the M1 and M4 mAChR subtypes, although with lower affinity. The replacement of MT7 loop III and the tip of loop II by their counterparts in MT1 (Fig. 4c) , generated a MT7/1 chimera with 162-fold greater affinity for the M1 mAChR subtype compared to toxin MT1, without altering its affinity for the M4 subtype. Hence, this chimera exemplifies a novel M1 mAChR-specific ligand since it binds to M1 with 2000-fold higher affinity than to M4. For MT7, these modifications involve virtually no loss of affinity for M1 (4-fold) but a 52-fold improvement for M4 binding. Here again, a crystallographic study demonstrated not only that the 3FT scaffold is conserved in all the chimeric toxins but also that the transplanted loops conserve their original 'parental' structure.
Conclusion
Among all the physiological systems affected by the superfamily of endogenous (Ly6-uPAR family members) and exogenous (3FTs) three-finger fold proteins, the cholinergic system appears to be particularly targeted by proteins able to block or modulate the functions of cholinergic receptors or ACh-binding proteins. Several of these 3FPs have become useful tools for studying the function and the structure of their molecular targets. Most importantly, since dysfunction of these receptors is involved in many diseases, the three-finger scaffold may be exploited to engineer novel, highly specific therapeutic agents.
